MODERATOR
:
SPEAKER
(S):
Erik Woods, PhD, President, Cook General Biotechnology
Novel Devices, Technologies and Strategies for Cryopreservation of Cell Products
Aby Mathew, PhD, Senior Director of Strategic Relations and Senior Scientist, BioLife Solutions, Inc.
Optimizing Biopreservation Solutions for Tissue and Blood Derived Cells for Cell Therapy
Dr. Jason Acker, PhD, MBA, Senior Development Scientist, Canadian Blood Services
Advances in RBC Preservation
Description
The expanding arena for cell therapies utilizes cell products sourced from blood, marrow, and tissues. The success/efficiency of the cell therapy is potentially affected by the periods of preservation, which includes transport of the source material and preservation of the final cell therapy product. This workshop will address the science behind current biopreservation, the pitfalls that are both recognized and often unrecognized, and new technologies that improve the final cell therapy product in terms of efficacy, quality/regulatory and cost efficiency.
-
Explain current practice of red blood cell and cord blood stem cell preservation, and potential issues resulting in sub-optimal systems with potential clinical impact on cell therapies.
-
Present new technologies that may potentially improve the landscape of cell preservation for cell therapy.
-
Review the science behind current cryopreservation/biopreservation methodologies.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.